442 related articles for article (PubMed ID: 31820218)
1. Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults.
Lin LA; Brummett CM; Waljee JF; Englesbe MJ; Gunaseelan V; Bohnert ASB
J Gen Intern Med; 2020 Feb; 35(2):420-427. PubMed ID: 31820218
[TBL] [Abstract][Full Text] [Related]
2. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
[TBL] [Abstract][Full Text] [Related]
3. Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose.
Weiner SG; Carroll AD; Brisbon NM; Rodriguez CP; Covahey C; Stringfellow EJ; DiGennaro C; Jalali MS; Wakeman SE
J Subst Abuse Treat; 2022 Aug; 139():108785. PubMed ID: 35537918
[TBL] [Abstract][Full Text] [Related]
4. Individual and Community Factors Associated with Naloxone Co-prescribing Among Long-term Opioid Patients: a Retrospective Analysis.
Stein BD; Smart R; Jones CM; Sheng F; Powell D; Sorbero M
J Gen Intern Med; 2021 Oct; 36(10):2952-2957. PubMed ID: 33598891
[TBL] [Abstract][Full Text] [Related]
5. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
[TBL] [Abstract][Full Text] [Related]
6. Associations between naloxone prescribing and opioid overdose among patients with acute and chronic pain conditions.
Qeadan F; Madden EF
Addiction; 2022 Feb; 117(2):457-471. PubMed ID: 34286895
[TBL] [Abstract][Full Text] [Related]
7. Legal requirements and recommendations to prescribe naloxone.
Haffajee RL; Cherney S; Smart R
Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
[TBL] [Abstract][Full Text] [Related]
8. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania.
Pizzicato LN; Johnson CC; Viner KM
Subst Abus; 2020; 41(3):301-306. PubMed ID: 31644397
[No Abstract] [Full Text] [Related]
9. Naloxone dispensing among the commercially insured population in the United States from 2015 to 2018.
Dunphy C; Zhang K; Guy GP; Jones CM
Prev Med; 2021 Dec; 153():106820. PubMed ID: 34599923
[TBL] [Abstract][Full Text] [Related]
10. Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18.
Stein BD; Jones CM; Smart R; Sheng F; Sorbero M
Drug Alcohol Depend; 2021 Apr; 221():108569. PubMed ID: 33578296
[TBL] [Abstract][Full Text] [Related]
11. Rates and Costs of Dispensing Naloxone to Patients at High Risk for Opioid Overdose in the United States, 2014-2018.
Barenie RE; Gagne JJ; Kesselheim AS; Pawar A; Tong A; Luo J; Bateman BT
Drug Saf; 2020 Jul; 43(7):669-675. PubMed ID: 32180134
[TBL] [Abstract][Full Text] [Related]
12. Impact of an emergency department opioid prescribing guideline on emergency physician behaviour and incidence of overdose in the Saskatoon Health Region: a retrospective pre-post implementation analysis.
Hartmann RJ; Elder JD; Terrett LA
CMAJ Open; 2021; 9(1):E79-E86. PubMed ID: 33514601
[TBL] [Abstract][Full Text] [Related]
13. Differences in Naloxone Prescribing by Patient Age, Ethnicity, and Clinic Location Among Patients at High-Risk of Opioid Overdose.
Kispert D; Carwile JL; Silvia KB; Eisenhardt EB; Thakarar K
J Gen Intern Med; 2020 May; 35(5):1603-1605. PubMed ID: 31625039
[No Abstract] [Full Text] [Related]
14. Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose.
Follman S; Arora VM; Lyttle C; Moore PQ; Pho MT
JAMA Netw Open; 2019 May; 2(5):e193209. PubMed ID: 31050777
[TBL] [Abstract][Full Text] [Related]
15. Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal.
Kilaru AS; Liu M; Gupta R; Perrone J; Delgado MK; Meisel ZF; Lowenstein M
Am J Emerg Med; 2021 Sep; 47():154-157. PubMed ID: 33812332
[TBL] [Abstract][Full Text] [Related]
16. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults.
Nguyen AP; Glanz JM; Narwaney KJ; Binswanger IA
JAMA Netw Open; 2020 Mar; 3(3):e201018. PubMed ID: 32219404
[TBL] [Abstract][Full Text] [Related]
17. Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations.
Ellis MS; Kasper ZA; Gold M; Cicero TJ
J Addict Med; 2023 Mar-Apr 01; 17(2):197-205. PubMed ID: 36148998
[TBL] [Abstract][Full Text] [Related]
18. Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic Trial.
Binswanger IA; Rinehart D; Mueller SR; Narwaney KJ; Stowell M; Wagner N; Xu S; Hanratty R; Blum J; McVaney K; Glanz JM
J Gen Intern Med; 2022 Aug; 37(11):2624-2633. PubMed ID: 35132556
[TBL] [Abstract][Full Text] [Related]
19. Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high-strength opioids for chronic non-cancer pain: An explorative intervention development study.
Mercer F; Parkes T; Foster R; Steven D; McAuley A; Baldacchino A; Steele W; Schofield J; Matheson C
Drug Alcohol Rev; 2023 Mar; 42(3):517-526. PubMed ID: 36165733
[TBL] [Abstract][Full Text] [Related]
20. Association of Opioid Prescribing Patterns With Prescription Opioid Overdose in Adolescents and Young Adults.
Chua KP; Brummett CM; Conti RM; Bohnert A
JAMA Pediatr; 2020 Feb; 174(2):141-148. PubMed ID: 31841589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
